Enjoy complimentary customisation on priority with our Enterprise License!
The protein detection and quantification market size is forecast to increase by USD 767.7 billion at a CAGR of 6.2% between 2023 and 2028. Protein detection plays a crucial role in various applications, including diagnostics, drug identification, and biomarker discovery for chronic diseases such as neurological disorders, cancers, and diabetes. The market for protein detection and quantification is experiencing significant growth due to increasing advances in proteomics research and the rising popularity of personalized medicine. The use of protein detection kits and reagents facilitates the identification and measurement of specific proteins, enabling early and accurate diagnosis and effective treatment. However, the lack of skilled laboratory professionals poses a challenge to the market's growth. The market is expected to grow steadily due to the increasing prevalence of chronic diseases and the need for more precise and personalized healthcare solutions.
Protein detection and quantification play a pivotal role in various industries, including diagnostics, pharmaceuticals, and biotechnology. The ability to accurately detect and measure proteins is essential for disease diagnosis, drug identification, and development. This market encompasses a range of techniques and technologies, including colorimetric assays, immunological methods, mass spectrometry, and proteomics. Proteins serve as crucial biomarkers for various chronic diseases, neurological disorders, and cancers. In personalized medicine, protein detection and quantification enable the development of targeted therapies for individual patients. For instance, identifying specific proteins associated with diabetes or cancer can lead to the creation of customized treatment plans. Diagnostic applications of protein detection and quantification are vast, with techniques such as immunoassays and fluorescence techniques being commonly used. These methods allow for the sensitive and specific detection of proteins, aiding in the diagnosis of diseases like cancer and neurological disorders. The pharmaceutical industry relies heavily on protein detection and quantification for drug development. Understanding the interaction between proteins and drugs is crucial for optimizing drug efficacy and minimizing potential side effects. Proteomics techniques, such as mass spectrometry and immunoassays, are instrumental in this process.
Furthermore, biomarker identification is another significant application of protein detection and quantification. Biomarkers are indicators of various physiological or pathological conditions, and their detection can lead to earlier and more accurate disease diagnosis. Proteins serve as essential biomarkers for various diseases, including cancer and diabetes. Protein quantification is a critical aspect of protein detection, as it allows for the measurement of protein concentration in biological samples. This information is valuable for understanding protein function and for the development of therapeutics and diagnostics. In conclusion, the market is a vital component of various industries, including diagnostics, pharmaceuticals, and biotechnology. The ability to accurately detect and measure proteins is essential for disease diagnosis, drug development, and personalized medicine. Techniques such as colorimetric assays, immunological methods, mass spectrometry, and proteomics are used to achieve these goals. Proteins serve as crucial biomarkers for various diseases, and their detection and quantification can lead to earlier and more accurate diagnosis, optimized drug development, and personalized treatment plans.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The kits and reagents segment is estimated to witness significant growth during the forecast period.Protein detection and quantification is a crucial aspect of various industries, including diagnostics, drug identification, and personalized medicine. The market for protein detection and quantification is significant, with a major contribution coming from the kits and reagents segment. The high utility and frequent usage of these products make them a large revenue generator in this market. Additionally, the affordability of kits and reagents, especially when purchased with compatible instruments, is a significant factor driving their adoption. Protein crystallization, a key application of protein detection and quantification, further boosts the demand for these products.
Further, chronic diseases such as neurological disorders, cancers, and diabetes are among the areas where protein detection and quantification plays a vital role in research and diagnostics. Biomarkers derived from proteins are essential in identifying and monitoring these conditions, making the market for protein detection and quantification a growing one. Key players in this market include companies offering kits and reagents for protein detection and quantification, contributing to its expansion.
Get a glance at the market share of various segments Request Free Sample
The kits and reagents segment accounted for USD 773.70 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
Protein detection and quantification play a crucial role in medical research and drug development in North America. The significant investment in healthcare research and testing in the United States, coupled with strong distribution networks in countries such as the US and Canada, fuels the growth of the regional market. The increasing focus of pharmaceutical companies on discovering and developing new drugs further boosts market expansion. The healthcare sector in North America has witnessed increased spending, leading to a rise in the number of research projects, particularly in the field of regenerative medicine.
Additionally, proteomics techniques, including mass spectrometry and immunoassays, are widely used for protein quantification and biomarker identification, which are essential for disease diagnosis. Assay kits are in high demand due to their ease of use and accuracy in protein measurement. In summary, the North American market is thriving due to the region's strong healthcare infrastructure, research focus, and pharmaceutical industry investments.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing advances in proteomics research is the key driver of the market. Proteins are essential biological molecules that carry out various functions in the human body. Two significant types of proteins are antibodies and enzymes. Antibodies act as the body's defense mechanism by binding to foreign particles such as viruses or bacteria, while enzymes facilitate biochemical reactions, including digestion and cell growth. Proteomics research encompasses the large-scale study of proteins and the techniques used to analyze them. Understanding post-translational modifications of proteins is crucial, as these modifications directly impact protein function. Advanced instruments, such as chromatography, spectroscopy, and high-throughput assays, play a pivotal role in protein profiling and characterization. Point-of-Care Testing (POC) has gained popularity due to its convenience and quick results.
Monoclonal antibodies and enzymes are widely used in research and diagnostics for their specificity and sensitivity. Protein detection and quantification are essential in various industries, including pharmaceuticals, biotechnology, and healthcare, for the development of therapeutics, diagnostics, and biomarkers. Protein research continues to advance, providing valuable insights into disease mechanisms and potential therapeutic targets.
The increasing popularity of personalized medicine is the upcoming trend in the market. Protein detection and quantification play a significant role in the advancement of personalized medicine, allowing for early disease detection and accurate treatment selection, ultimately reducing mortality rates. Microarray technology is a crucial tool in this field, facilitating the analysis of genetic compositions and inherited syndromes contributing to diseases like cardiovascular conditions and cancer. The increasing understanding of genetic diseases fuels the growth of personalized medicine, focusing on targeted drug development. Recombinant proteins, such as Beta-Amyloid and Tau Proteins, are essential in the research and development of solutions for diseases like Alzheimer's disease. Protein-based assays are an integral part of this process, enabling the precise measurement and identification of these proteins.
Environmental testing and food safety applications also benefit from protein detection and quantification technologies, ensuring public health and safety. Genetic modification is another area where these solutions are valuable, offering insights into the molecular mechanisms of various genetic disorders. The application of protein detection and quantification techniques in various industries, including healthcare, food, and environmental sectors, is expanding. The growing importance of personalized medicine, driven by advancements in genetic research, is expected to continue fueling the demand for these solutions.
The lack of skilled laboratory professionals is a key challenge affecting the market growth. Protein detection and quantification play a crucial role in the biopharmaceutical industry, particularly in areas such as cancer research and clinical diagnostics. Proteomics, a branch of science that deals with the large-scale analysis of proteins, is at the forefront of these applications. Techniques like fluorescence and spectroscopy are commonly used for protein analysis in high-throughput screening. As regulatory requirements evolve, such as the In Vitro Diagnostic Regulation (IVDR), the need for accurate and reliable protein analysis becomes even more critical. Clinical trials and research projects depend on precise protein quantification for meaningful results. Protein analysis is a complex process that requires careful consideration of factors like molecular weight, buffer solutions, and protein stability.
The medical laboratory science sector faces a significant workforce shortage, making it essential for researchers to have a deep understanding of protein research techniques. By employing advanced methods like protein detection and quantification, researchers can contribute to groundbreaking discoveries in various fields, including cancer research and clinical diagnostics. In summary, protein detection and quantification are essential steps in biopharmaceutical research and clinical diagnostics. The application of advanced techniques like fluorescence, spectroscopy, and high-throughput screening enables researchers to gain valuable insights into protein behavior and contribute to the development of new treatments and diagnostic tools. Despite the challenges posed by workforce shortages, the importance of protein analysis in scientific research remains undeniable.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abcam plc - The company offers protein detection and quantification through its BCA Protein Quantification Kit.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Protein detection and quantification play a significant role in various industries, including biotechnology, pharmaceutical, and healthcare sectors. The increasing prevalence of chronic diseases such as neurological disorders, cancers, and diabetes, has led to a swell in demand for protein detection and quantification techniques. These techniques are essential for personalized medicine, diagnostics, drug identification, and biomarker discovery. Protein detection is crucial in drug discovery and clinical diagnosis, particularly in hospitals and diagnostic centers. Proteomics techniques, such as mass spectrometry, immunoassays, and chromatography, are widely used for protein quantification and biomarker identification. Protein characterization and protein profiling are essential for disease diagnosis and treatment efficiency. Assay kits and instruments, including spectroscopy, fluorescence techniques, and high-throughput assays, are used for protein analysis.
Additionally, monoclonal antibodies and enzymes are commonly used in protein-based assays for cancer subtypes and other health conditions. High-throughput screening and IVDR-approved spectroscopy instruments are used in clinical trials. Protein detection and quantification are also essential in environmental testing and food safety. Genetic modification and the development of biopharmaceutical products require precise protein analysis. Proteins, such as beta-amyloid and tau proteins, are critical in the diagnosis and treatment of Alzheimer's disease. Overall, protein detection and quantification are vital in medical research, drug development, and healthcare infrastructure.
Market Scope |
|
Report Coverage |
Details |
Page number |
139 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.2% |
Market Growth 2024-2028 |
USD 767.7 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.8 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key countries |
US, Germany, Canada, China, and UK |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abcam plc, Agilent Technologies Inc., Bio Rad Laboratories Inc., Biofidus AG, Cell Signaling Technology Inc., Danaher Corp., General Electric Co., Inanovate Inc., Intertek Group Plc, Labome, Laboratoire AGUETTANT, Merck KGaA, Molecular Device LLC, Perkin Elmer Inc., Promega Corp., Protagen Protein Services GmbH, RayBiotech Life Inc., Sartorius AG, Shimadzu Corp., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.